Caron Treatment Centers Expands Addiction Programs for Adults in Florida Caron Treatment Centers, a nationally recognized nonprofit dedicated to addiction and behavioral healthcare treatment, research, prevention, and education, has announced a significant expansion of its services in Florida. Beginning in…
Wheeler Bio Raises $35M in Oversubscribed Series, Plans Expansion Wheeler Bio, a pioneering contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of antibody-based therapies, has successfully closed an oversubscribed Series A-1 financing round, raising $35…
Lightship Names Darcy Forman as COO to Drive Growth and Efficiency Lightship, a pioneering provider of community-based and decentralized clinical trial services, has announced the appointment of Darcy Forman as Chief Operating Officer (COO). In this strategic role, Forman will…
Valo Health Names Peggy Dalicandro VP, Head of HR Valo Health, Inc. (“Valo”), a pioneering biotechnology company dedicated to revolutionizing the drug discovery and development process through the integration of human-centric data and artificial intelligence (AI), has announced the appointment…
ICON First Large CRO to Fully Integrate Medidata Clinical Data Studio Medidata, a Dassault Systèmes brand and a leading provider of clinical trial solutions, has announced that ICON plc (NASDAQ: ICLR), a global clinical research organization (CRO) specializing in healthcare…
Frazier Healthcare Secures Minority Investment from Goldman Sachs’ Petershill Frazier Healthcare Partners, a prominent healthcare-focused private capital firm based in Seattle, has announced a strategic minority investment from Petershill at Goldman Sachs Alternatives (“Petershill”). While the specific terms of the…
Veracyte Showcases Decipher & MRD Test Insights in Urologic Cancers at EAU25 Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, has announced that eight abstracts highlighting the performance and clinical utility of its Decipher and minimal residual disease (MRD)…
RADIANT Trial Shows Significant Glycemic Gains with Omnipod® 5 After MDI Transition Insulet Corporation (NASDAQ: PODD), a global leader in tubeless insulin pump technology through its Omnipod® brand, has released new clinical data from its RADIANT study, demonstrating significant glycemic…
FDA Clears Quibim’s QP-Prostate® CAD for Lesion Detection and Diagnosis Quibim, a global leader in imaging biomarkers for precision medicine, has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting 510(k) clearance for its QP-Prostate® CAD…
Nexus Pharmaceuticals Expands Portfolio with the Launch of Tranexamic Acid Nexus Pharmaceuticals, LLC has announced the official launch of Tranexamic Acid, marking a significant milestone in the company’s ongoing commitment to providing life-saving medications. This addition to Nexus’ growing pharmaceutical…